Tag Archives: enzymatic converted blood

Toward enzymatic blood conversion: A promising solution for blood shortage and transfusion incompatibility

What do you do when a patient requires blood transfusion, but the specific blood type is inadequate in the blood bank? Blood shortage has become a concern worldwide. According to American Red Cross, approximate 36,000 units of red blood cells (RBCs) are needed daily in the U.S, yet 13 million units are collected in a year, resulting in an average daily shortage of 400 units. And, this crisis usually expands during extraordinary situations. A recent example is the critical blood shortage during COVID-19 pandemic.

To solve the challenge, chemists have taken a step forward to examine the structure of RBCs and consider what if we convert all blood types to the universally accepted O blood. The importance of such research is that the barrier of blood transfusion between different types no longer exists. Hence, blood supply increases to ease the shortage.

What are blood types and transfusional barrier?

Image credit: InvictaHOG

There are four major blood types: A, B, AB, and O. Although blood might look the same and do the same job, such as carrying oxygen for respiration, transfusing incompatible blood type will trigger fatal immune responses. That is because of the additional sugar molecule, called antigen, attaching to the core sugar structure on a RBC. Type A blood has A antigens. Similarly, type B blood has B antigens. Moreover, type AB blood contains both A and B antigens. Importantly, type O has none of them.

Image credit: Marius Lixandru

Due to the presence of either A or B antigen, A-blood people cannot transfuse with type B; B-blood people cannot transfuse with type A. Consequently, AB-blood people cannot take either A or B but only with AB blood. Only O blood is the universally accepted type because it shares without being recognized as an outsider by our immune system.

Origin of enzymatic blood conversion

The first idea of blood-type conversion can be traced back to 1980s, Goldstein and his colleagues used an enzyme found in coffee beans and have shown success in the complete enzymatic removal of B antigen, generating non-antigen blood (O blood). However, the conversion requires large quantity of enzymes and output a trace amount of type O. As a result, the work done by Goldstein is not suitable for practical use. Similarly, other research uses an enzyme found in fungi to remove A antigen but its efficiency is still inadequate.

Improving enzyme activity using enzyme engineering

YouTube Preview Image

Description: How enzymes found in gut bacteria change blood types for transfusion

Great improvement in enzyme activity is recently done by Kwan’s team who modify sugar hydrolase (GH98) with 170-times higher enzyme activity than that of the original hydrolase from human gut bacteria using enzyme engineering. It is inspiring because GH98 enzyme can remove both A and B antigens, whereas other enzymes used in past research only remove either A or B antigens. Their research broadens the specificity of the enzyme and makes the blood conversion more promising and practical for resolving blood shortage.

– Calvin Pan